Sara Riordan

Sara Riordan, M.S., CGC, is the Vice President of Strategy at Genome Medical. In this role, she develops and implements long-term strategies that advance the adoption of Genome Medical's genetic services and the broader landscape of rare disease care. Previously, Sara served as Vice President of Clinical and Research Programs at Unified Patient Network and held roles at Thermo Fisher Scientific, Life Technologies, and Oncocyte, in addition to consulting roles with several early-stage companies on genomic test development and commercialization. Sara served as the 2021 President of the National Society of Genetic Counselors, where she focused on growing a diverse workforce, advocating for equitable access to genetic counselor services, and leading the development of the organization's 2022-2024 strategic plan.